Free Research Reports on ARNA, REGN, THOR and TWO Issued by the Bedford Report

NEW YORK, NY -- (Marketwired) -- 05/06/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares declined 9.16 percent on volume of over 20.0 million shares traded Friday to close at $7.63 a share. The company announced it has withdrawn its European marketing application for its weight loss drug Belviq and plans to resubmit it at a later date.

Find out more about Arena Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/ARNA

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) shares spiked 7.05 percent on volume of over 2.3 million shares traded Friday to close at $266.16 a share. The company reported sales of EYLEA in the U.S. totaled $314 million for the first quarter of 2013, a sharp increase from sales of $124 million in the year ago quarter.

Find out more about Regeneron Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/REGN

Thoratec Corp. (NASDAQ: THOR) shares declined 10.76 percent on volume of over 5.0 million shares traded Friday to close at $32.59 a share. The company reported GAAP net income fell to $18.2 million, or $0.31 per diluted share, for the first quarter of 2013, from $25.5 million, or $0.43 per diluted share, a year prior.

Find out more about Thoratec including full access to the free equity report at: www.BedfordReport.com/THOR

Two Harbors Investment Corp. (NYSE: TWO) shares have gained approximately 4.25 percent year-to-date. The company currently offers investors a quarterly dividend of $0.32 per share, $1.28 per share annually, for a dividend yield of roughly 11.10 percent.

Find out more about Two Harbors Investment including full access to the free equity report at: www.BedfordReport.com/TWO

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.